Multiple Myeloma Research Foundation logo

Multiple Myeloma Research Foundation

North America, Connecticut, United States, Norwalk

Description

Multiple Myeloma Research Foundation is a non-profit organization that offers treatment for cancer.

Investor Profile

Multiple Myeloma Research Foundation has made 4 investments, with 0 in the past 12 months and 75% as lead.

Stage Focus

  • Grant (75%)
  • Series A (25%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Clinical Trials
  • Hospital
  • Pharmaceutical
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Multiple Myeloma Research Foundation frequently co-invest with?

MI
North America, Massachusetts, United States, Brookline
Co-Investments: 1
Northpond Ventures
North America, Maryland, United States, Bethesda
Co-Investments: 1
Leaps by Bayer
Europe, Nordrhein-Westfalen, Germany, Leverkusen
Co-Investments: 1
B Capital
North America, California, United States, Manhattan Beach
Co-Investments: 1
ATEM Capital Fund LP
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Multiple Myeloma Research Foundation?

Mount Sinai Health System

New York, New York, United States

Mount Sinai Health System delivers integrated medical care, research, and medical education through its network.

Health CareHospitalMedical
GrantNov 2, 2023
Amount Raised: $7,000,000
Triumvira Immunologics

Austin, Texas, United States

Triumvira Immunologics is an immunotherapy company that develops novel T cell therapies for cancer.

BiotechnologyClinical TrialsHealth Care
Series AMar 17, 2022
Amount Raised: $45,000,000
Karyopharm Therapeutics

Newton, Massachusetts, United States

Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for the treatment of cancer and other major diseases.

Health CareMedicalPharmaceutical
GrantJan 6, 2011
Amount Raised: $1,000,000
Epizyme

Cambridge, Massachusetts, United States

Epizyme is a biopharmaceutical company focusing on treatments for blood cancer and tumors.

BiopharmaBiotechnologyHealth Care
GrantJan 6, 2011
Amount Raised: $1,000,000